Lindbrook Capital’s Smith & Wesson SWBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
$9 Hold
1
﹤0.01% 2775
2024
Q4
$10 Hold
1
﹤0.01% 2768
2024
Q3
$13 Hold
1
﹤0.01% 2818
2024
Q2
$14 Hold
1
﹤0.01% 2752
2024
Q1
$17 Hold
1
﹤0.01% 2638
2023
Q4
$14 Hold
1
﹤0.01% 2684
2023
Q3
$13 Hold
1
﹤0.01% 2678
2023
Q2
$13 Hold
1
﹤0.01% 2699
2023
Q1
$12 Hold
1
﹤0.01% 2766
2022
Q4
$9 Sell
1
-11
-92% -$116 ﹤0.01% 2817
2022
Q3
$0 Sell
12
-119
-91% -$1.57K ﹤0.01% 2899
2022
Q2
$2K Buy
131
+130
+13,000% +$1.89K ﹤0.01% 2055
2022
Q1
$0 Sell
1
-226
-100% -$3.8K ﹤0.01% 2611
2021
Q4
$4K Hold
227
﹤0.01% 1608
2021
Q3
$5K Hold
227
﹤0.01% 1262
2021
Q2
$8K Buy
+227
New +$4.75K ﹤0.01% 1152

Other funds holding SWBI

Lindbrook Capital's SWBI Position: Q1 2025 in Review

Lindbrook Capital held its Smith & Wesson (SWBI) position steady in Q1 2025 at 1 share worth $9. The position accounts for ﹤0.01% of the portfolio, ranked #2775.

Lindbrook Capital first reported a position in SWBI in Q2 2021 and has held it in 16 quarters since. The position peaked at $8K in Q2 2021. 175 funds tracked by Wall St. Rank hold SWBI as of Q1 2025.

  • Lindbrook Capital held 1 share of Smith & Wesson worth $9 as of Q1 2025.
  • Lindbrook Capital left its Smith & Wesson share count unchanged in Q1 2025.
  • Smith & Wesson made up ﹤0.01% of Lindbrook Capital's portfolio in Q1 2025, its #2775 holding.
  • Lindbrook Capital first reported a position in Smith & Wesson in Q2 2021 and has held it in 16 quarters since.
  • Lindbrook Capital's Smith & Wesson position peaked at $8K in Q2 2021.
  • 175 funds tracked by Wall St. Rank held Smith & Wesson as of Q1 2025.

Based on Lindbrook Capital's 13F filing for Q1 2025, filed 5 May 2025.